BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang Y, Fu LJ, Chen CM, Hu MW. Venetoclax in combination with chidamide and dexamethasone in relapsed/refractory primary plasma cell leukemia without t(11;14): A case report. World J Clin Cases 2021; 9(5): 1175-1183 [PMID: 33644182 DOI: 10.12998/wjcc.v9.i5.1175]
URL: https://www.wjgnet.com/2307-8960/full/v9/i5/1175.htm
Number Citing Articles
1
Han‐Yu Cao, Ling Li, Sheng‐Li Xue, Hai‐Ping Dai. Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancyHematological Oncology 2023; 41(3): 301 doi: 10.1002/hon.3088
2
AntineoplasticsReactions Weekly 2021; 1864(1): 41 doi: 10.1007/s40278-021-98971-2